[{"Assets_0_FY_USD":18677000.0,"CommonStockSharesOutstanding_0_FY_shares":39356999.0,"EarningsPerShareBasic_4_FY_USD":-0.52,"EarningsPerShareDiluted_4_FY_USD":-0.52,"NetIncomeLoss_1_FY_USD":-6116000.0,"NetIncomeLoss_4_FY_USD":-18485000.0,"StockholdersEquity_0_FY_USD":13336000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":35343765.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":35343765.0,"Ticker":"EYPT","CIK":"1314102","name":"PSIVIDA CORP.","OfficialName":"EyePoint Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20170630","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"408871503.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170913"}]